CorFlow Therapeutics AG Company

CorFlow Therapeutics AG is a startup that creates their own technologies to help diagnose and treat microvascular obstructions in heart attack patients. Their technologies can help reduce short- and long-term complications in severe heart attack patients.


Investors

Industry: Medical Technology
Estimated Revenue: Less than $1M
Headquarters: Zug